ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Daniel J. Goldstein
Mehmet C. Oz
Eric A. Rose
Robert E. Michler
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldstein, D. J.
Right arrow Articles by Michler, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldstein, D. J.
Right arrow Articles by Michler, R. E.

Ann Thorac Surg 1995;60:1783-1789
© 1995 The Society of Thoracic Surgeons

Articles

De novo solid malignancies after cardiac transplantation

MD Daniel J. Goldstein, RN Deborah L. Williams, MD Mehmet C. Oz, MS Alan D. Weinberg, MD Eric A. Rose, MD Robert E. Michler*

Division of Cardiothoracic Surgery, Department of Surgery, Columbia University College of Physicians & Surgeons, New York, New York, USA

Accepted for publication August 11, 1995.

* Address reprint requests to Dr Michler, Milstein Hospital, 7th Fl, 177 Ft Washington Ave, New York, NY 10032.

Background.: As long-term survival after cardiac transplantation improves, neoplastic complications are increasingly being discovered. Although lymphoproliferative disorders predominate, the incidence and clinical spectrum of solid tumors in a uniform population of heart transplant recipients remains uncertain.

Methods.: We reviewed our experience with 712 patients who underwent cardiac transplantation. Clinical charts were reviewed and telephone interviews were conducted, when possible.

Results.: De novo solid malignancies were identified in 3.3% of patients at risk (21 of 633 patients). Twenty patients were male; mean age was 51.5 ± 8.6 years. Most patients reported a significant smoking history. Pulmonary, urologic, and Kaposi's sarcoma were the most common malignancies identified. Mean interval from transplantation to diagnosis was 35 months. Six patients were diagnosed within 6 months of transplantation. One-year and 5-year survival after transplantation were 90% and 49%, respectively. One-year and 3-year survival after cancer diagnosis were 60% and 52%, respectively.

Conclusions.: De novo solid malignancy after transplantation occurred with about half the frequency of lymphoproliferative disorders. A striking male predominance was noted. The interval from transplantation to the appearance of cancer is variable, and no clustering was identified. A significant smoking history warrants aggressive search for occult malignancy during pretransplantation evaluation of potential heart recipients.




This article has been cited by other articles:


Home page
 Pulmonary Manifestations of Systemic DiseasesHome page
L. J. Dupont and G. M. Verleden
Noninfectious pulmonary complications after organ transplantation
Pulmonary Manifestations of Systemic Diseases, June 28, 2010; 202 - 219.
[Abstract] [Fulltext] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
R.-B. Hsu, C.-I. Chang, M.-K. Tsai, P.-H. Lee, N.-K. Chou, N.-H. Chi, S.-S. Wang, and S.-H. Chu
Low incidence of malignancy in heart-transplant recipients in Taiwan: an update and comparison with kidney-transplant recipients
Eur J Cardiothorac Surg, May 1, 2010; 37(5): 1117 - 1121.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
P. Bagan, F. L. P. Barthes, and M. Riquet
Prognosis of Lung Cancer in Heart Transplant Recipient
Ann. Thorac. Surg., January 1, 2006; 81(1): 409 - 409.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
K. Potaris, B. Radovancevic, C. D. Thomas, I. Gregoric, A. A. Vaporciyan, S. A. Riggs, R. Radovancevic, W. K. Vaughn, and O.H. Frazier
Lung Cancer After Heart Transplantation: A 17-Year Experience
Ann. Thorac. Surg., March 1, 2005; 79(3): 980 - 983.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
P. Bagan, J. Assouad, P. Berna, R. Souilamas, F. Le Pimpec Barthes, and M. Riquet
Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients
Ann. Thorac. Surg., February 1, 2005; 79(2): 438 - 442.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
Z. Ahmed, M. B. Marshall, J. C. Kucharczuk, L. R. Kaiser, and J. B. Shrager
Lung Cancer in Transplant Recipients: A Single-Institution Experience
Arch Surg, August 1, 2004; 139(8): 902 - 906.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. Lenner, M. L. Padilla, A. S. Teirstein, A. Gass, and G. J. Schilero
Pulmonary Complications in Cardiac Transplant Recipients
Chest, August 1, 2001; 120(2): 508 - 513.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
M. Rinaldi, C. Pellegrini, A. M. D'Armini, M. Aiello, M. Negri, E. Arbustini, G. Ippoliti, and M. Vigano
Neoplastic disease after heart transplantation: single center experience
Eur J Cardiothorac Surg, May 1, 2001; 19(5): 696 - 701.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
I. Penn
Solid tumors in cardiac allograft recipients
Ann. Thorac. Surg., December 1, 1995; 60(6): 1559 - 1560.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.